Company Update Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain. Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.
Company Update Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain. Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.
Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par
Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par
Company Update USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru
Company Update USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru USFDA Inspection of Shilpa Medicare Limited at Unit VI, Dabaspet, Bengaluru
General Updates Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru
General Updates Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit VI, Dabaspet, Bengaluru
SHILPA MEDICARE Q3 FY25 Results
SHILPA MEDICARE Q2 FY25 Results
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.
Filings and alerts in WhatsApp or Telegram
Focus on news that matter most to you
Track 5 companies at no cost. Upgrade anytime.